Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608192 · ClinicalTrials.gov registry record · NA
HIV and Hepatitis Care Coordination in Methadone Treatment
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 489
- Enrollment target
NCT00608192: Completed NA study, sponsored by University of California, San Francisco.
NCT00608192 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 489 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608192, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 489 participants
- Enrollment target
Study Summary
This randomized clinical trial will examine the effectiveness of a strategy of HIV and Hepatitis Care Coordination (HCC) consisting of testing, education, counseling and vaccination for methadone maintenance patients compared with standard Testing, Education, and Counseling (TEC).
Interventions
- BEHAVIORAL Testing, Education, & Counseling (TEC)
- BEHAVIORAL Hepatitis Care Coordination (HCC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 489 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT00608192 record still lists
NCT00608192 is an interventional study that assigns participants to a tested intervention. The registered 489 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Testing, Education, & Counseling (TEC) is the first listed.
NCT00608192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00608192 about?
NCT00608192 is a clinical study titled "HIV and Hepatitis Care Coordination in Methadone Treatment". This randomized clinical trial will examine the effectiveness of a strategy of HIV and Hepatitis Care Coordination (HCC) consisting of testing, education, counseling and vaccination for methadone maintenance patients compared with standard Testing, Education, and Counseling (TEC).
What is the current status of trial NCT00608192?
This trial is currently completed. It is a NA study. The enrollment target is 489 participants. The study started on 2008-01. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00608192?
The interventions under investigation include: Testing, Education, & Counseling (TEC) (BEHAVIORAL), Hepatitis Care Coordination (HCC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00608192?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00608192's enrollment target sits among peer trials
489 215th of 2000 higher than 1,786 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia